DA - Food Innovation DA - MSDI 2022
DA - Food Innovation DA - MSDI 2022.docx
Indexed text preview
Food Innovation DA 1NC Biotech is strong now – hiring rates prove Data Journalism Team, 22, (Data Journalism Team, The data journalism team works across GlobalData's media portfolio, providing data driven analysis from the company's proprietary datasets., 3-21-2022, Pharmaceutical Technology, North America is seeing a hiring boom in pharmaceutical industry big data roles, https://www.pharmaceutical-technology.com/analysis/north-america-is-seeing-a-hiring-boom-in-pharmaceutical-industry-big-data-roles/, 7-2-2022) SCade North America extended its dominance for big data hiring among pharmaceutical industry companies in the three months ending January. The number of roles in North America made up 64% of total big data jobs – up from 59.7% in the same quarter last year. That was followed by Asia-Pacific, which saw a -0.9 year-on-year percentage point change in big data roles. The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically. GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries. These key themes, which include big data, are chosen to cover "any issue that keeps a CEO awake at night". By tracking them across job advertisements it allows us to see which companies are leading the way on specific issues and which are dragging their heels - and importantly where the market is expanding and contracting. Which countries are seeing the most growth for big data job ads in the pharmaceutical industry? The fastest growing country was the United States, which saw 57.6% of all big data job adverts in the three months ending January 2021, increasing to 61.4% in the three months ending January this year. That was followed by India (up 1.9 percentage points), Canada (0.5), and the United Kingdom (-0.199999999999999). The top country for big data roles in the pharmaceutical industry is the United States which saw 61.4% of all roles advertised in the three months ending January. gene editing is key to innovation Claire O’Connell, 11-14-2019, Claire O'Connell is a contributor to The Irish Times who writes about health, science and innovation "Why gene editing is decade’s most significant innovation", Irish Times, https://www.irishtimes.com/business/innovation/why-gene-editing-is-decade-s-most-significant-innovation-1.4080666, 6-28-2022, //ms gene editing (like the other innovations) has been in the works for a while, the last seven years have seen major developments in our ability to specifically edit DNA in living cells. It is not without controversy. Recent claims that human embryos in China had been genetically edited and had resulted in twin babies prompted widespread condemnation from scientists, as well as discussions about safety and ethics and calls for effective regulation. But as a technology, the ability to alter a gene in a living cell offers many potential benefits, including treating inherited diseases, understanding what specific genes do, generating more resilient crops and even detecting species in the environment. "The field is amazing," says Jane Farrar, a professor of genetics at Trinity College Dublin. "I have had some very late nights updating my lecture slides for undergraduates, because so much in gene technology is happening so quickly." Gene editing – which directly changes the “letters” of the genome – is becoming more of a feature of gene therapy, notes Farrar, but it is the new kid on the block. “The ability to edit specific genes in living cells is relatively new,” she says. “That means many forms of gene therapy that have by now reached the clinic or are under late-stage development don’t use these new gene-editing techniques. They deliver the gene into the cell, rather than correcting or editing the DNA,” she notes. Farrar was one of the pioneers of gene therapy research in Ireland in the 1980s and 1990s, when the patient-led charity Fighting Blindness supported work to find the genetic changes linked to inherited forms of vision loss. “The eye is really an ideal place for gene therapy,” she explains. “It is accessible, it can tolerate the viruses used to deliver genes and you have a natural control – if you put the gene therapy in one eye you can compare it to the other over time.” Rare eye disease Farrar, Prof Pete Humphries and colleagues identified gene changes involved in a rare eye disease called retinitis pigmentosa, and developed a system to "rescue" the gene function by suppressing the mutant gene and delivering a new gene into the cell. The technology was acquired by Spark Therapeutics in 2016. In 2017, the FDA in the USA approved a different Spark therapy, Luxturna, which replaces the function of gene changes associated with progressive sight loss. It was the first gene therapy of its kind to be approved in the US. “In general, there’s a huge amount of commercial interest in new gene therapies,” says Farrar. “Plenty more are in the works, not just for inherited eye diseases but also for rare diseases that affect how cells break down cellular components to recycle them, conditions that damage the mitochondria [which act as “batteries” in cells] and spinal and central nervous system disorders, among others.” She believes that gene editing will become more common in gene therapy approaches in the coming years, particularly as we work out how to do it safely and effectively. “With gene editing, there is the potential risk of ‘off-targets’, where editing a target gene could bring about unintentional changes in the genome or cell function, so some researchers are looking for ‘safe harbours’ in DNA,” she explains. “These are stretches of DNA where in principle you could add different genes targeting different disorders, while avoiding negative off-target effects.” The availability of gene editing in recent years also means that scientists can now use it as a research tool to target specific stretches of DNA relatively easily, according to Prof Breandan Kennedy, a senior lecturer at University College Dublin. Probably the best known gene-editing technology is CRISPR-Cas9, which was made commercially available in 2012. A little like having a sat-nav and a scissors, CRISPR-Cas systems allows you target a specific sequence of DNA “letters” in a living cell, then cut the sequence at that point. ‘Very powerful’ “By doing this, we can inactivate a specific gene, and this gives us a lot of information about what that gene normally does,” says Kennedy, whose work at UCD school of biomolecular and biomedical science uses gene editing technology on microscopic worms, zebrafish and human cells in the lab. “By inactivating specific genes, which we can do much more quickly and easily now with CRISPR-Cas systems, our group has been able to identify genes that are important for vision, for eye development and for blood vessels in the eye to grow and work properly. We are also using the approach to validate in the lab whether particular DNA change in patients are involved in inherited eye disease. Ten years ago if you said such a technology would be widespread, people would have laughed, but now labs around the world can do this. It’s very powerful.” Plant science, too, is reaping the rewards of being able to target specific stretches of DNA in living cells. "What is possible now is what was impossible five years ago," says Dr Ewen Mullins, head of the crop science department at Teagasc, Oak Park. “The holy grail for plant breeding is to be able to control the activity of a single gene, or several linked genes, and now gene editing allows us to do that,” he says. “And crucially, we are not necessarily adding a gene in from another species. With CRISPR-Cas systems, we can edit the genes already in the plant.” This could help to make crop plants more resilient in the face of droughts, fluctuating temperatures and agents of disease, notes Mullins: “These are becoming issues for farmers in Ireland and other parts of the world now, and in the face of climate change we need to reduce those susceptibilities where we can into the future.” Identifying species Gene-editing technology can even help us to identify what species are living in a particular environment, as Dr Anne Parle-McDermott from Dublin City University is finding out. "We are looking at the different species of salmon that live in rivers and aquaculture, but we are doing that by analysing the DNA they shed, also known as environmental or e-DNA," she explains. "We can take a sample of water, then we add CRISPR to find unique stretches of DNA that tell us about the species it came from. The associated Cas protein then cuts a reporter DNA and we can detect that cutting activity, so we know that stretch of DNA is present in the sample. It gives us a whole new way of knowing what DNA is present in the environment." Dr Ciaran Seoighe, deputy director general at Science Foundation Ireland, is impressed that gene technology won the reader vote for the innovation of the decade. "CRISPR-Cas9 is a case of a discovery turned into an innovation," he says. "Decades ago, researchers were discovering that bacteria had this system of being able to find and cut DNA in viruses and so stop them attacking, and the innovation was to take that and use it to specifically edit genes ourselves. It was a case of finding something interesting and then doing something different with it. Now it provides a tool for researchers to work on more personalised approaches to medicine." Farrar is also impressed by the winning vote. “I think the readers are very insightful,” she says. “Gene technology has matured in the last decade, and thanks to gene-editing technology we can also now get far more understanding about disease. This is really a story of fundamental biology enabling a new technology. Without that curiosity, we might not have these exciting innovations now.” The biotech industry solves for food shortages brought on by climate change via innovation Elsevier, 14, (Elsevier, 2014, Elsevier, The agrochemicals industry takes on climate change https://www.elsevier.com/?a=196459, 6-25-2021) SCade Food Shortage Fears Frustratingly, climate change threatens to damage and lessen the planet’s food supply at a time when we need more food than ever. The worldwide population continues to explode, meaning that it’s not just about protecting the current supply, but also being prepared to grow it substantially to meet an ever-greater global demand. The United Nations has declared that food production must double by 2050 in order to feed the burgeoning population, one billion of whom are already suffering from hunger. This is a concern that is raised again and again among those working in agrochemicals, who feel a great responsibility to see their industry meet this vital need. Biotech to the Rescue “I’m a big believer in biotech and the doors that it can open,” says Madden, who was working at Asgrow (a seed company owned by Monsanto) when the first biotechnology products were introduced in the 1990s. “Humanity is dependent on crop breeding in combination with biotechnology to keep up with climate change.” Advances in biotechnology have made it possible to genetically modify crops with traits that make them resistant to pests and diseases. This not only helps farmers fight off problems that may result from climate change, but it also means that they contribute less to it themselves. Why? When farmers get better yields, they need less land to grow on – therefore slowing deforestation and the greenhouse gas emissions that come with it. And there is so much more that biotech could do to actively fight climate change. In a piece in The Berkeley Blog, author David Zilberman suggests that one such innovation could be to make GM soybean crops with improved digestibility, so that the cattle eating them release fewer greenhouse gases. Researchers are working on biotechnology that could solve any number of problems related to climate change, but it can be a long and arduous process of trial and error, as they attempt to find effective solutions. GM crops that are resistant to drought, for example, would be a godsend for farmers, but Madden explains that though “drought tolerance has been worked on for quite a while, early gene products have been somewhat disappointing to companies based on what is offered and achieved. ”He points out that regional differences in rainfall and soil type, as well as climate shifts, can complicate matters. Food price increases causes scarcity and war over the remaining food and land Ore Koren, 16, (Ore Koren, Ore Koren is a PhD candidate at the University of Minnesota and a Jennings Randolph Fellow at the United States Institute of Peace., 11-23-2016, Washington Post, Food scarcity causes conflicts — but so can food abundance. Here’s why., https://www.washingtonpost.com/news/monkey-cage/wp/2016/11/23/food-scarcity-causes-conflicts-but-so-does-food-abundance-heres-why/, 6-28-2021) SCade For a new U.S. administration facing global security challenges, the relationship between food security — what the World Bank defines as “access to enough food for an active, healthy life” — and armed conflict deserves serious consideration. As new research shows, even an abundance of food resources can cause conflict. Recent studies theorize that in Syria, where an estimated 250,000 to 400,000 people have died since 2011, the drought that preceded the civil war played a significant role in fueling political tensions. Increases in food prices caused by drought were also a factor in the 2011 Arab Spring uprisings in Tunisia, Jordan, Yemen and Egypt. The fact that prolonged food shortages can lead to drastic, violent behavior is becoming increasingly evident. The relationship between food and war is both complex and multidimensional, though. The links between food scarcity and war Warmer countries are more war-prone — that’s what researchers studying the relationships between environmental factors and civil war argue. As global temperatures increase, prolonged heat waves reduce crop yields. The impact is strongest in tropical regions, which are more likely to experience the harshest effects of global warming. Lower crop yields increase the competition for remaining crops. And rising prices mean that many people cannot afford to buy food to compensate for resources lost because of climatic shifts. In countries that lack a social “safety net,” the only alternative in many cases is to obtain food through stealing, looting and — frequently — fighting over fertile land. Anecdotal evidence from eastern Africa and the Middle East, at least, supports this theory. Attempts to measure the linkages between climate change and armed conflict, however, have yielded mixed results, with some studies at least partly reaffirming these connections and others debunking them. Some regions adapt to climate conditions better than others Studies of the “Green Revolution” movement of the 1960s suggest that regions such as Asia were far more successful than Africa at adopting drought-resistant crops, which improved food security and helped offset the risk of war. Similar efforts in sub-Saharan Africa and the Middle East were weak and generally unsuccessful until the late 1980s. These efforts met with limited success because of the types of grain available and other socioeconomic complexities, which left these regions food insecure. Had Syria successfully adopted drought-resistant crops, for instance, the social unrest of 2011 might have taken a different, less-violent course. As researchers continue to debate how climate change and its effects on global food stocks will impact food security in future decades, short-term environmental “shocks” such as droughts or floods have become more frequent in many parts of the world and are a potentially salient cause of armed conflict. These environmental disturbances can lead to sharp price increases that, in turn, can cause another well-established tradition: the food riot, when civilians take to the streets to protest high food prices. Low-income countries are particularly susceptible because high food prices in these situations have an especially destabilizing effect. In these countries, high food prices expose the government’s lack of ability to shield consumers. They also create opportunities for civilians to mobilize against the regime. Even in locations where food is sourced locally, drought-induced shocks may incite violence against civilians when rebel groups seek to appropriate local food supplies. My research documents this happening not only in the Syrian conflict but also in India and Thailand during a 2004 drought. Riots, protests and massacres are among the types of unrest that can lead to civil war — and all can be linked to food conflicts. 2NC DA turns case Tech and national response key to fight bioterror Stockholm International Peace Research Institute, 19, (Stockholm International Peace Research Institute, 3-27-2019, 8-16-2021, World Economic Forum, < https://www.weforum.org/agenda/2019/03/how-emerging-technologies-increase-the-threat-from-biological-weapons/ > Blucas The main conclusion is that, while new developments in these three emerging technologies could have an enabling effect in different steps of the development and use of biological weapons, the existing governance frameworks are ill-equipped to comprehensively address these risks. To improve the ability to govern the convergence of biotechnology with other emerging technologies, concrete steps could be taken by national governments, regional organizations such as the European Union (EU) and international institutions, and by academia, the private sector and the DIY community. National governments should more systematically assess technological developments, map domestic stakeholders, make use of parliamentary assessment mechanisms, increase resources for relevant authorities, and strengthen research on the detection, prevention, response and attribution of biological incidents. The EU should enhance engagement with the biotechnology industry and biosafety associations in the context of dual-use risks. The BTWC regime should reform some of its elements, including its working practices and stakeholder engagement, and create a BTWC Scientific Advisory Board. It could also raise the issue of convergence on its agenda and better address the potential for misuse of commercial biotechnology and emerging technologies. Academic institutions should introduce obligatory courses on ethics, law and biosafety in all natural science curriculums, encourage work on interdisciplinary technology assessments and further strengthen the collaboration between national academies of sciences, particularly on addressing risks resulting from technological convergence. The private sector should continuously strengthen its self-governance and compliance standards. The DIY community could organize workshop series on biosecurity for community laboratories and strengthen international efforts to foster responsible science and biosecurity awareness. 2NC---Biotech Links Big pharma is partnering with germline developers now---the aff puts a stop to that innovation Annalee Armstrong, Apr 5, 2022, Annalee Armstrong is a senior editor for Fierce Biotech. Prior to joining Fierce in April 2021, Annalee was an associate editor for S&P Global Market Intelligence’s healthcare news team. Before that, she was the EPA reporter covering climate and energy policy on the Hill in Washington, D.C. Annalee got her start in journalism at daily newspapers across Western Canada chasing sled dogs and other stories. In her free time, Annalee enjoys yoga, camping and exploring the Blue Ridge Mountains from her home base in Charlottesville, Virginia. "Big Pharma partnershi
Preview shortened. Download the file for the full document.